Clinical Trial Update: Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating treatment for elderly fit patients (65–80) with newly diagnosed multiple myeloma; status ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: PETHEMA Foundation | Conditions: Newly Diagnosed Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING